Study of BMS-986012 in Subjects With Small Cell Lung Caner

NCT02949895 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: BMS-986012
DRUG: Cisplatin
DRUG: Etoposide

Sponsor

Bristol-Myers Squibb